Eltrombopag Olamine
NDC 60219-1417, Eltrombopag, tablet, film coated, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 60219-1417
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212884
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1417 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELTROMBOPAG OLAMINE12.5 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Increased Megakaryocyte Maturation [PE]; Increased Platelet Production [PE]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Thrombopoietin Receptor Agonist [EPC]; Thrombopoietin Receptor Agonists [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A3 Inhibitors [MoA]; UGT1A4 Inhibitors [MoA]; UGT1A6 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]; UGT2B15 Inhibitors [MoA]; UGT2B7 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60219-1417-3 | 60219141703 | 30 TABLET, FILM COATED in 1 BOTTLE (60219-1417-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/05acf38e-7870-4809-a045-fc38e66b1110
Use it
Look up 60219-1417 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1417 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60219-1417. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.